Drs. Adami & Schwartz awarded NCI grant to study “Green tea effects on gene expression in tobacco users”
Posted on 10/10/2013

Congratulations to Drs. Guy Adami and Joel Schwartz on their National Cancer Institute grant, “Green tea effects on gene expression in tobacco users”. Drs. Adami and Schwartz’s pilot study noninvasively obtained cells from human smokers, and showed green tea can reverse some early effects of carcinogen exposure in some people. The hypothesis of the newly funded study, is that cells obtained from the mouth, using noninvasive methods, can be used to determine what consumptions of five cups of green tea per day does to the epithelial cell functions in tobacco smokers. The penultimate goal is providing a testable method to detect green tea induced changes associated with tumor inhibition so individual who might benefit from green tea consumption can be rapidly identified.

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), one of eleven agencies that constitute the U.S. Department of Health and Human Services. The NCI coordinates the U.S. National Cancer Program and conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.